Jupiter Neurosciences (JUNS) traded up 15.5 % during a 24 hours period ending at 05:52 AM Central Europe on Tuesday 27th. One Jupiter Neurosciences stock can currently be bought for about USD 2.86 on popular exchanges. Current supply of Jupiter Neurosciences stocks is 1.3 mn. Jupiter Neurosciences has a current market capitalization of USD 3.9 mn and approximately USD 59 k worth of Jupiter Neurosciences was traded on exchanges in the last 24 hours. Since last month end, Jupiter Neurosciences has traded 3.29 % up. Simple moving average of last 200 days is at USD 22.32. The highest price of past 52 weeks was recorded at USD 135.75 on 10/28/2025. 52 weeks low was at USD 2.25 on 10/06/2026.
Here is how related stocks have performed in the past 24 hours:
Dna X (SONM) traded down -3.48 % and now trades at USD 2.96. Current market capitalisation for Dna X is USD 4.6 mn.
Dragonfly Energy (DFLI) traded down -9.43 % and now trades at USD 2.29. Dragonfly Energy has a market capitalisation of USD 4.5 mn.
Senestech (SNES) traded up 5.13 % and now trades at USD 0.85. Senestech has a market capitalisation of USD 4.6 mn.
Apimeds Us I (APUS) traded down -8.54 % and now trades at USD 2.9. Apimeds Us I has a market capitalisation of USD 4.4 mn.
Envveno Medical (NVNO) traded down -3.76 % and now trades at USD 6.71. Current market capitalisation for Envveno Medical is USD 4.6 mn.
About Jupiter Neurosciences
Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company based in the United States with its main operations located in Jupiter. The company specializes in developing resveratrol products that reach therapeutic levels without causing gastrointestinal side effects, making it effective in treating neuro-inflammation. Jupiter Neurosciences serves customers in Florida. You can find more information about their work on their website www.jupiterneurosciences.com or through trading on the Nasdaq stock exchange.